Younger patients with diabetes face increased risk of death.
Read More »Metformin Reduces Hospitalizations Associated with Heart Failure
Metformin is one of the oldest antihyperglycemic drugs still in practice, but recent research confirms its benefits.
Read More »Dapagliflozin and its Heart Failure Benefit
Could a newer diabetes medication provided clinicians with an alternative when managing heart failure?
Read More »Glucose Control and Cardiovascular Disease – 15 Year Follow-up
Does intensive glucose control show heart benefits in long-term followup?.
Read More »Can Statins increase the Risk of Skin Infection?
New research attempts to untangle the conflicting literature on whether statins and SSTIs are linked.
Read More »Diabetes Patients At Risk for Myocardial Infarctions Even Without CAD
DE-MRI shows asymptomatic patients are undergoing small, silent heart attacks.
Read More »Resistant Hypertension Predicts Mortality Outcomes in T2D
Resistant hypertension and type 2 diabetes lead to both microvascular and macrovascular complications.
Read More »Cardiovascular and Renal Benefits of SGLT2 Inhibitors
The use of SGLT-2 inhibitors produces cardiovascular benefits and reduces the risk of progression of renal impairment in patients with T2DM.
Read More »What does Resistant Hypertension Mean for Diabetes Patients?
Can a diagnosis of resistant hypertension give clinicians a clue on what patients can expect for their future?
Read More »Prevalence of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes
Can using DE-MRI image scans determine the prevalence of unrecognized MIs in asymptomatic patients with diabetes?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.